G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
GMVD was delisted on the 23rd of August, 2023.
6 hedge funds and large institutions have $709K invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
27% less capital invested
Capital invested by funds: $973K → $709K (-$264K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$224K |
| 2 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$107K |
| 3 |
TCM
Tradewinds Capital Management
Bellingham,
Washington
|
+$63.3K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$19.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$330K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SSA
1
Schonfeld Strategic Advisors
New York
| $272K | +$19.8K | +188 | +6% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $166K | +$224K | +2,126 | New |
|
3
JP Morgan Chase
New York
| $137K | +$2.11K | +20 | +1% |
|
|
SFI
4
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $80K | +$107K | +1,016 | New |
|
|
TCM
5
Tradewinds Capital Management
Bellingham,
Washington
| $47K | +$63.3K | +600 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $7K | +$9.81K | +93 | New |
|
|
PVH
7
Psagot Value Holdings
Tel Aviv,
Israel
| – | -$330K | -2,571 | Closed |
|
GMVD Hedge Fund Activity: Q3 2021 in Review
6 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q3 2021, worth a combined $709K — down 27% from $973K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GMVD positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $224K. The largest seller was Psagot Value Holdings, exiting entirely with an estimated $330K sold.
- 6 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q3 2021, up from 3 in Q2 2021.
- Funds reported $709K of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q3 2021, down 27% quarter-over-quarter.
- 4 funds opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q3 2021 and 1 closed out, a net change of +3 holders.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares buyer in Q3 2021 was Geode Capital Management, an estimated $224K added.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares seller in Q3 2021 was Psagot Value Holdings, an estimated $330K sold.
Based on aggregated 13F filings for Q3 2021.